The large and small-scale bioprocessing global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Large And Small-Scale Bioprocessing Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size – The large and small-scale bioprocessing market size has grown rapidly in recent years. It will grow from $52.59 billion in 2023 to $59.63 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to medical industry growth, regulatory standards, technological advancements, pharmaceutical and biotechnology growth, and food safety concerns.
The large and small-scale bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $99.03 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing healthcare expenditure, the expansion of pharmaceutical and biotechnology sectors, technological innovations, regulatory pressures, rising awareness of food safety, and the aftermath of the COVID-19 pandemic. Major trends in the forecast period include the adoption of advanced technologies, geographical expansion, outsourcing of sterilization services, sustainable practices, hybrid sterilization techniques, and customized sterilization solutions.
Order your report now for swift delivery @
Scope Of Large And Small-Scale Bioprocessing Market
The Business Research Company’s reports encompass a wide range of information, including:
Large And Small-Scale Bioprocessing Market Overview
Market Drivers -The growing demand for biologics is expected to propel the growth of the large and small-scale bioprocessing market going forward. Biologics refer to medicinal products derived from living organisms or their components, including vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. The growing demand for biologics is due to advancements in biotechnology, increased understanding of disease mechanisms, and the demand for targeted and personalized therapies. Both large-scale and small-scale bioprocessing are integral to biologics’ successful development and commercialization. Small-scale bioprocessing is essential for early-stage development, optimization, and feasibility studies. In contrast, large-scale bioprocessing ensures that biologics are produced efficiently, consistently, and in compliance with regulatory standards for commercial distribution. For instance, in February 2024, according to the National Library of Medicine, a US-based medical library, in 2023, the Food and Drug Administration (FDA) approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the growing demand for biologics drives the growth of the large and small-scale bioprocessing market.
Market Trends – Major companies operating in the large and small-scale bioprocessing market are developing innovative products, such as single-use centrifuge systems, to serve customers with advanced features better. Single-use centrifuge systems are disposable, pre-sterilized centrifugation devices designed for separating biological materials in bioprocessing. For instance, in September 2022, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched the DynaSpin Single-Use Centrifuge system. This system is designed to improve large-scale cell culture harvesting by streamlining the separation process, reducing the number of depth filtration cartridges needed, and offering benefits such as improved product yield, operational efficiency, cost savings, and sustainable practices in biologics production. The DynaSpin system helps reduce production costs and supports sustainability goals by significantly decreasing material requirements and waste compared to traditional harvest systems.
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids
Get an inside scoop of the large and small-scale bioprocessing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
Regional Insights – North America was the largest region in the large and small-scale bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies – Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, 3M Company, Takeda Pharmaceutical Company Ltd., Danaher Corporation, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Becton Dickinson and Company (BD), Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Lonza Group, Sun Pharmaceutical Industries Ltd., GE Healthcare Life Sciences, Sartorius AG, Dr. Reddy’s Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd
Table of Contents
………..
Read Related Reports:
https://goodprnews.com/glycerol-derivatives-market-size/
https://topprnews.com/hotel-staff-task-management-software-market-share/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The warmer display cases global market report 2024 from The Business Research Company provides comprehensive…
The veterinary renal disease global market report 2024from The Business Research Company provides comprehensive market…
The spring loaded industrial cable reels global market report 2024 from The Business Research Company…
The secure data destruction global market report 2024 from The Business Research Company provides comprehensive…
The qr code payments global market report 2024 from The Business Research Company provides comprehensive…
The plastic additives global market report 2024 from The Business Research Company provides comprehensive market…